Based on breakthrough findings from Dr. Adams' lab uncovering a novel druggable cellular detoxification pathway driving Cisplatin resistance in NSCLC, this collaboration aims to design novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results